HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?

Search
EmailWire News Links

Home > News By Company > Beacon Equity

Print e mail rss del
Y! myWeb


Technical Trade Alerts on Market Movers: SSVE, ENZN, SNMX, VECO, STEC, SIMG

News in the services, healthcare and technology industries drove market activity, though many companies failed to secure positive ground in the shadow of the overall negative market.

(EMAILWIRE.COM, November 21, 2008 ) DALLAS, Texas – Beacon Equity Research announces the release of Trade Alerts covering market movers: SupportSave Solutions Inc. (OTCBB: SSVE), Enzon Pharmaceuticals Inc. (Nasdaq: ENZN), Senomyx Inc. (Nasdaq: SNMX), Veeco Instruments Inc. (Nasdaq: VECO), STEC Inc. (Nasdaq: STEC) and Silicon Image Inc. (Nasdaq: SIMG).

In the Trade Alert, the author highlights SupportSave Solutions’ selection by national provider of home cleaning equipment for outsourced support:

“SupportSave Solutions Inc. (SSVE) shares slipped 7.50% Wednesday, closing at 37 cents. SupportSave Solutions is a leading provider of low-cost customer care services and business process outsourcing solutions (BPO) for small and mid-sized companies. … The company recently announced the award of a one-year contract to support consumers for a nationally recognized supplier of home cleaning equipment whose products are available for sale or rental in most national chains. … With SupportSave's low cost model, 60% to 80% lower than the industry average, CEO Chris Johns stated, ‘It is no surprise, then, that we were selected over several competitors to provide customer service and technical support for this nationally-recognized supplier of home cleaning equipment.’”

The Trade Alert author also featured Enzon’s reporting of solid third-quarter financial results:

“Enzon Pharmaceuticals Inc. (ENZN) shares rose 12.19% Wednesday, closing at $4.05. Enzon is a biopharmaceutical company focused on the development, manufacturing and commercialization of medicines for patients with cancer and other life-threatening conditions. … Enzon Pharmaceuticals recently released solid third-quarter 2008 financial results. For the three months ended September 30, 2008, the company reported a net loss of $2 million or 5 cents on a diluted per-share basis, as compared to a net income of $87.5 million or $1.23 on a diluted per-share basis for the third quarter of 2007. In 2007, the third-quarter results were impacted by the $88.7 million net gain from the sale of a portion of its PEG-INTRON royalty asset.”


Investors can view all of the TraderNotes and investment articles for free by visiting:
http://www.beaconequity.com/m

Join the fastest growing investor community at:
http://www.stockhideout.com

BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m

BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com

Beacon Equity Research Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

The report is a service of BlueWave Advisors, LLC, a financial public relations firm that has been compensated by the companies profiled. All direct and third party compensation received has been disclosed within each individual profile in accordance with section 17(b) of the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BlueWave Advisors, LLC, and/or its affiliated will hold, buy, and sell securities in the companies profiled. When compensated in shares, all readers should be aware that is our policy to liquidate all shares immediately. We reserve the right to buy or sell the shares of any the companies mentioned in any materials we produce at any time. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BeaconEquity.com is a Web site wholly-owned by BlueWave Advisors, LLC. BlueWave Advisors, LLC has been compensated thirty five thousand dollars from Whitney Funding, a shareholder of SSVE, as a marketing budget to manage a comprehensive investor awareness program including the creation and distribution of this report as well as other investor relations efforts.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org

Source: BeaconEquity.com

Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com

Contact Information:
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
Press Release Keywords:

stock market, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, supportsave solutions inc., enzon pharmaceuticals inc., senomyx inc., veeco instrumen

Stop Being Fooled By "Penny Stock Picks"
Subscribe To The #1 Rated MicroCap Stock Newsletter.
MicroCapster.com





Top Penny Stock TEMN


Key Investment Highlights & Latest News on Gainer TEMN!
StockSource.us/temn.html

Your text Ads here!
Ads are only $575 per month. Ads are placed same day. Contac Us

Emailwire.com/contact.php




Press release service and press release distribution on EmailWire.Com is a global newswire of GroupWeb Media LLC.

 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Setup Co-Branding

© Copyright GroupWeb.com 2007